Groowe / Newsroom / ATNM

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ATNM News

Actinium Pharmaceuticals, Inc

Actinium to Present ATNM-400 Preclinical Data Highlighting Durable Tumor Control and Ability to Overcome Resistance to Standard-of-Care Prostate Cancer Therapies at the 32nd Annual Prostate Cancer Foundation Scientific Retreat

prnewswire.com Oct 13, 2025 2:31 PM